hh contract award ihm updat ventil need hme
addit detail respiratori support landscap read-through
depart human servic hh award ventil contract
name coverag see ventil analysi piec ventil suppli demand
predict unpredict
billion wednesday april hh releas detail two major
ventil contract cumul account approxim billion
ventil deliv govern year-end follow
presid trump action invok defens product act dpa april help
secur ventil suppli philip hill-rom
ventil ad strateg nation stockpil nsn
expect distribut state as-need basi even maintain
back-up potenti futur pandem nsn ventil prior
expect look replenish bolster suppli come
pandem expect govern domest entiti acquir
ventil would suggest ultim near- medium-term market domest
invas ventil like meaning higher billion current award
especi factor purchas non-invasive system like aircurv
even precis earli april state new york alon order
niv machin phillip
origin ventil updat link highlight rumor approxim
billion total govern contract discuss impli least anoth
million remain allot contract award week one april
hh announc explicitli say five firm mention invok dpa
receiv rate contract come week result think may see contract
updat come week
believ compani well posit term technolog
scalabl meaning part potenti contract award recent
highlight expect increas ventil output time end
june compar pre-pandem level increas per week today
per week june expect manufactur invas vent
next month similarli recent manag call ceo mick farrel note
compani manufactur million respiratori support devic annual
know exact split invas vs non-invasive ventil think demonstr
compani abil flex manufactur output meet near-term demand
pleas refer import disclosur page analyst certif page
william blair affili seek busi compani cover research report
result investor awar firm may conflict interest could affect object
report report intend provid person invest advic opinion recommend
herein take account individu client circumst object need intend
recommend particular secur financi instrument strategi particular client recipi
report must make independ decis regard secur financi instrument mention
addit background two contract award april specif philip
contract million million respect total ventil year-end
gener motor reportedli partner ventec life system manufactur vocsn ventil expect
philipp suppli trilog system believ life-sav astral stellar ventil offer similar
capabl contract devic posit player potenti next contract award either
unit state abroad especi consid abil provid non-invasive solut well
updat estim ventil need univers washington medicin institut health metric evalu
ihm provid detail resourc util estim updat almost daili basi given wide variabl
predict spread scenario resourc estim meaning chang real-world data use fine-tun
forward project less two week ago origin publish ventil market updat ihm data impli
peak need ventil assum patient requir week support devic
reus april ihm data impli peak ventil usag around system lower
estim two week ago repres approxim less immedi ventil need decreas
million need assum asp roughli asp above-ment contract
believ lower estim caus input real-world data show better-than-expect result hot spot
like new york case hospit start come better lower expect said
even real-world data remain highli volatil expect creat similar degre variabl ventil need
ihm estim recent updat also provid resourc util estim key intern countri look
data spain germani itali alon three european hotspot assum need ventil
estim peak demand three countri billion invas ventil opportun
still miss intern hot spot though note base ventil alreadi place base ihm
estim could greater billion intermedi need ventil across globe coronaviru
spread much investor attent focus need expect major player like
key player global market given abil scale manufactur global presenc
impact interim rule care act seem posit hme world updat gather
week relat hme services/devic
recal march releas interim rule suggest agenc relax requir provid care
medicar patient pandem would suggest ncd/lcd requir suspend includ
requir around oxygen sleep test two primari takeaway weve heard last week
first hme see patient get discharg hospit oxygen patient necessarili
requir chronic oxygen care mani clinician use rule thumb dont need treat
hospit set impact ultim unknown though direct posit
compani like particularli given anecdot data suggest oxygen suppli shortag
second hme see home sleep test provid promot servic pandem recal
typic complet sleep studi requir submit claim cpap devic though
requir current suspend mean patient would complet in-lab home sleep studi
gain access cpap eventu look requalifi patient brought hme
complet home sleep studi today could submit futur net net though would still
anticip new cpap start materi on-going pandem relax rule interest
home sleep test posit manufactur like
third also paus prior author requir certain dmepo item though claim
similarli review follow pandem help eas barrier access particularli
mani clinicians/clin data unavail
also note care act extend blend rate rural supplier institut blend rate
non-rur non-bid area pandem recent hme present held hme news suggest sever
geographi latter chang provid increas reimburs may prove relief hme
though claim need reprocess higher rate give hme comfort around cash
lastli payer broadli seem support telehealth treat diagnos patient patient also seem comfort
reach clinicians/healthcar servic provid virtual care recal someth mani home health-
focus compani suggest could limit impact pandem offer solut
overwhelm health system first signal spoke manag tactil medic earlier
week compani report materi slowdown mid-march bounce-back demand later march discuss
manag describ note encourag signal end-of-march rebound home-bas solut
stock thought valuat risk
share trade time calendar ep estim growth year-over-year near term
off-set headwind ventil sale ad certainti next quarter execut
ventil updat week dpa increas industri output leav us increment confid
abil execut next quarter
though compani yet direct larg hh contract believ meaning provid vent
domest also intern extent compani abl particip determin
product capac manag suggest part determin abil gain access unit
sub-compon someth believ multipl global compani tri activ help sourc numer
context sold nearli million total america devic sale prior six month million global
compar million million contract award hh phillip gm earlier week
continu look updat hh organ next sever week
beyond near-term vent demand came away week encourag patient advocaci effort around treatment
home believ beneficiari near-term mid- long-term broadli
continu believ long runway ahead main growth segment sleep copd hcit
drive long-term share momentum rate stock outperform
risk oper competit market new competit product could stifl compani growth profil
compani also invest meaning saa busi like need time prove meaning roi
exposur countri across world includ fx manufacturing/oper china singapor
also like creat headwind within core sleep busi short term
stock thought valuat risk
trade time unchang revenu estim growth believ well closest
peer though continu assum see much benefit hospit demand vent eas
oxygen access could provid small tailwind anecdot feedback week
patient leav hospit oxygen true beneficiari eas restrict
reimburs relief also direct posit said impact busi remain
somewhat uncertain though believ risk/reward profil favor particularli long-term investor
rate stock outperform
risk oper competit market barrier entri low consum exposur capit
equip strategi higher degre volatil expos consum spend
stock thought valuat risk
share trade sale estim million growth med-tech growth peer though
directli mention hh believ could part smaller scale rel
larger player given recent public comment around tripl manufactur capac think
compani could see result bullish scenario output sale long-term
believ sustain momentum market share convers benefit expanding/matur sale forc
new product launch rate stock outperform
risk face competit larger establish market incumb compani yet profit
pace adopt invest may affect time break-even cash need
stock thought risk expect major player meet need ventil
come month remain cautiou compani abil meet expect next sever quarter
mani much larger product segment suscept materi headwind said clearli
posit part solut think could bolster brand come global
pandem remain encourag number catalyst could togeth acceler top-lin growth midsingl
digit wait execut pipelin product move past market disrupt load
pipelin strong balanc sheet think core med tech investor may want look share past time
rate market fundament segment remain strong share trade time
unchang calendar ep estim line modestli large-cap peer rate share market
risk thesi includ better-than-anticip execut market adopt key pipelin product could
acceler top-lin growth subsequ drive strong share perform bottom line may abl
execut greater-than-anticip cost-sav initi subsequ reach better-than-expect ep drive share
price common stock public compani mention report follow
one research analyst respons cover inc mention report own share secur
william blair affili manag co-manag public offer equiti secur inc within prior
william blair affili market maker secur inc inc inc
william blair affili expect receiv intend seek compens invest bank servic inc
inc inc affili within next three month
william blair affili receiv compens invest bank servic non-investment-bank servic
inc within last month inc within last month invest bank client
william blair compani and/or one affili
offic employe william blair affili research analyst may financi interest secur
inc inc inc
report avail electron form regist user via doc http //williamblairlibrari bluematrix com
pleas contact us consult williamblair com/research-and-insights/equity-research/coverag aspx disclosur
